B. Lisboa
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
Papers in
-
- Breast Cancer Treatment Studies 10
- Cancer Genomics and Diagnostics 2
- Protease and Inhibitor Mechanisms 2
- Oncology 12
- Cancer Treatment and Pharmacology 7
- Co-authors
- Thomas Löning (3 shared papers)Karin Milde‐Langosch (3 shared papers)Christoph Thomssen (8 shared papers)Michael Untch (9 shared papers)Lutz Riethdorf (2 shared papers)Jan-Ακε Gustafsson (1 shared paper)Martin Schumacher (1 shared paper)Matthias Geberth (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (3 papers)European Journal of Cancer (2 papers)Cancer Research (2 papers)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
B. Lisboa
21 papers receiving 762 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 376
- Oncology 474
- Immunology and Allergy 76
- Genetics 207
- Reproductive Medicine 43
Countries citing papers authored by B. Lisboa
This map shows the geographic impact of B. Lisboa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Lisboa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Lisboa more than expected).
Fields of papers citing papers by B. Lisboa
This network shows the impact of papers produced by B. Lisboa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Lisboa. The network helps show where B. Lisboa may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Lisboa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 246 | |
| 2 | 2013 | 127 | |
| 3 | 1997 | 91 | |
| 4 | 1999 | 84 | |
| 5 | 2008 | 57 | |
| 6 | 1968 | 31 | |
| 7 | 1997 | 23 | |
| 8 | Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer. | 1997 | 23 |
| 9 | Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer. | 1996 | 21 |
| 10 | 2000 | 20 | |
| 11 | Metastatic breast cancer: experience with the combination paclitaxel plus epirubicin. | 1998 | 13 |
| 12 | 2009 | 13 | |
| 13 | 2009 | 8 | |
| 14 | 2005 | 7 | |
| 15 | 2003 | 5 | |
| 16 | 2006 | 5 | |
| 17 | 2012 | 4 | |
| 18 | 2002 | 3 | |
| 19 | 2008 | 3 | |
| 20 | 1997 | 2 |
About B. Lisboa
B. Lisboa is a scholar working on Cancer Research, Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine, having authored 23 papers that have together received 788 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Breast Lesions and Carcinomas (3 papers), Cell Adhesion Molecules Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Cancer Research (376 citations), Oncology (474 citations), Immunology and Allergy (76 citations), Genetics (207 citations) and Reproductive Medicine (43 citations). B. Lisboa has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Thomas Löning, Karin Milde‐Langosch, Christoph Thomssen, Michael Untch, Lutz Riethdorf, Jan-Ακε Gustafsson, Martin Schumacher, Matthias Geberth, Willi Sauerbrei and I. Fogelman. Their work appears in journals such as Journal of Clinical Oncology, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, European Journal of Cancer, Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.